MX2007003427A - Sintesis eficiente de 4,5-dihidro-pirazolo[3,4-c]pirid-2-onas. - Google Patents

Sintesis eficiente de 4,5-dihidro-pirazolo[3,4-c]pirid-2-onas.

Info

Publication number
MX2007003427A
MX2007003427A MX2007003427A MX2007003427A MX2007003427A MX 2007003427 A MX2007003427 A MX 2007003427A MX 2007003427 A MX2007003427 A MX 2007003427A MX 2007003427 A MX2007003427 A MX 2007003427A MX 2007003427 A MX2007003427 A MX 2007003427A
Authority
MX
Mexico
Prior art keywords
pyrid
pyrazolo
dihydro
ones
efficient synthesis
Prior art date
Application number
MX2007003427A
Other languages
English (en)
Spanish (es)
Inventor
Jing Liang
Bang-Chi Chen
Rulin Zhao
Boguslaw M Mudryk
Nicolas Cuniere
Dau-Ming Hsieh
Huiping Zhang
Lucius Rossano
Bei Wang
Adrian David
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX2007003427A publication Critical patent/MX2007003427A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2007003427A 2004-09-28 2005-09-27 Sintesis eficiente de 4,5-dihidro-pirazolo[3,4-c]pirid-2-onas. MX2007003427A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61375404P 2004-09-28 2004-09-28
US63762304P 2004-12-20 2004-12-20
US11/235,647 US7304157B2 (en) 2004-09-28 2005-09-26 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
PCT/US2005/034511 WO2006036926A2 (en) 2004-09-28 2005-09-27 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Publications (1)

Publication Number Publication Date
MX2007003427A true MX2007003427A (es) 2007-05-10

Family

ID=36100112

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003427A MX2007003427A (es) 2004-09-28 2005-09-27 Sintesis eficiente de 4,5-dihidro-pirazolo[3,4-c]pirid-2-onas.

Country Status (11)

Country Link
US (3) US7304157B2 (OSRAM)
EP (1) EP1805176A2 (OSRAM)
JP (1) JP2008514710A (OSRAM)
KR (1) KR20070067176A (OSRAM)
AU (1) AU2005289598A1 (OSRAM)
BR (1) BRPI0516172A (OSRAM)
CA (1) CA2582222A1 (OSRAM)
IL (1) IL182147A0 (OSRAM)
MX (1) MX2007003427A (OSRAM)
NO (1) NO20071634L (OSRAM)
WO (1) WO2006036926A2 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331526B (en) * 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
TW200303201A (en) * 2001-12-10 2003-09-01 Bristol Myers Squibb Co Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
AU2003205604B8 (en) * 2002-01-21 2009-12-24 Merck Sharp & Dohme B.V. Process for the preparation of 7alpha-methylsteroids
US20060069085A1 (en) * 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) * 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
RU2007126770A (ru) * 2004-12-15 2009-01-27 Бристол-Маерс Сквибб Компани (Us) Кристаллические формы ингибитора фактора ха
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
JP6667507B2 (ja) * 2014-09-02 2020-03-18 石薬集団中奇制薬技術（石家庄）有限公司 ピラゾロ［３，４−ｃ］ピリジン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5423698A (en) * 1994-03-30 1995-06-13 Molex Incorporated Electrical connector system for a video display tube yoke
AU2002341693B2 (en) 2001-09-21 2008-05-29 Bristol-Myers Squibb Holdings Ireland Unlimited Company Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
TWI331526B (en) * 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
TW200303201A (en) 2001-12-10 2003-09-01 Bristol Myers Squibb Co Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
US7396932B2 (en) 2004-09-28 2008-07-08 Bristol-Myers Squibb Company Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US20060069260A1 (en) 2004-09-28 2006-03-30 Huiping Zhang Preparation of N-aryl pyridones
US20060069085A1 (en) 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor

Also Published As

Publication number Publication date
CA2582222A1 (en) 2006-04-06
US7435821B2 (en) 2008-10-14
US7579472B2 (en) 2009-08-25
WO2006036926B1 (en) 2007-03-15
US20070282106A1 (en) 2007-12-06
US20080009626A1 (en) 2008-01-10
US7304157B2 (en) 2007-12-04
BRPI0516172A (pt) 2008-08-26
KR20070067176A (ko) 2007-06-27
US20060069119A1 (en) 2006-03-30
WO2006036926A3 (en) 2007-01-18
AU2005289598A1 (en) 2006-04-06
JP2008514710A (ja) 2008-05-08
WO2006036926A2 (en) 2006-04-06
EP1805176A2 (en) 2007-07-11
NO20071634L (no) 2007-06-21
IL182147A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
WO2007001385A3 (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
WO2003049681A3 (en) Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
MX2010001773A (es) Metodo para preparar derivados de 5-haloalquil-4,5-dihidroisoxasol .
IL190971A0 (en) Method and compounds for preparing cc-1065 analogs
GB0305142D0 (en) Synthesis
TW200519085A (en) Chemical compounds
SG158848A1 (en) Method for producing annelated piperazin-2-one derivatives and intermediates of said method
MY134701A (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
MXPA05011962A (es) Oxiarenos substituidos.
WO2006135425A3 (en) Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
MXPA05008183A (es) Proceso para preparar pirrolotriazina como inhibidores de cinasa.
MX2007003427A (es) Sintesis eficiente de 4,5-dihidro-pirazolo[3,4-c]pirid-2-onas.
WO2004030664A3 (en) New compounds for the inhibition of undesired cell proliferation and use thereof
TW200732338A (en) Aromatic compound
EP1555261A4 (en) VALEROLACTONE COMPOUNDS AND FRAGRANCE COMPOSITION
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
TW200612959A (en) Method for preparing hydroxamic acids
MXPA03002493A (es) Proceso eficiente para preparacion de un inhibidor del factor xa.
TW200626597A (en) Efficient synthesis of 4, 5-dihydro-pyrazolo [3, 4-c]pyrid-2-ones
TW200626596A (en) Preparation of 4 5-dihydro-pyrazolo[3, 4-c]pyrid-2-ones
TW200626595A (en) Process for preparing 4, 5-dihydro-pyrazolo [3, 4-c]pyrid-2-ones
TW200619201A (en) Process for the preparation of pyrazoles
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
TW200510430A (en) Process for synthesizing β -lactamase inhibitor intermediates

Legal Events

Date Code Title Description
FA Abandonment or withdrawal